Lipids in infectious diseases - The case of AIDS and tuberculosis

Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1636-1647. doi: 10.1016/j.bbamem.2017.05.007. Epub 2017 May 20.

Abstract

Lipids play a central role in many infectious diseases. AIDS (Acquired Immune Deficiency Syndrome) and tuberculosis are two of the deadliest infectious diseases to have struck mankind. The pathogens responsible for these diseases, Human Immunodeficiency Virus-1 and Mycobacterium tuberculosis, rely on lipids and on lipid membrane properties to gain access to their host cells, to persist in them and ultimately to egress from their hosts. In this Review, we discuss the life cycles of these pathogens and the roles played by lipids and membranes. We then give an overview of therapies that target lipid metabolism, modulate host membrane properties or implement lipid-based drug delivery systems. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribá.

Keywords: AIDS; HIV-1; Lipid; Membrane lipid-based therapies; Mycobacterium tuberculosis; Tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / etiology
  • Drug Delivery Systems
  • Humans
  • Lipid Metabolism
  • Membrane Fluidity / drug effects
  • Membrane Lipids / physiology*
  • Phagocytosis / drug effects
  • Tuberculosis / drug therapy*
  • Tuberculosis / etiology
  • Virus Assembly
  • Virus Internalization / drug effects

Substances

  • Membrane Lipids